Bautista, Remejane S.

HRN: 28-68-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2026
CEFUROXIME 750MG (VIAL)
03/08/2026
03/15/2026
IV
750mg
Q8h
Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaReproductive Tract    Compliance to guidelines: